FDA Enforcement Class II Terminated

ActCel advanced bleeding control Topical Hemostatic Dressing 2in X 2in (5cm X 5cm) 4in X 4in Sterile Contents Soluble Regenerated Cellulose For Bleeding Control For external topical and temporary use only Sterility of contents guaranteed unless individual envelope is damaged or opened. Store at room temperature (41F-104F). Do not autoclave.

Recall: Z-1697-2015 · Reported June 10, 2015

Enforcement

Recall Number
Z-1697-2015
Event ID
71279
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Coreva Health Science LLC
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
June 10, 2015
Initiation Date
May 18, 2015
Classification Date
May 30, 2015
Termination Date
August 26, 2015
Address
2985 E Hillcrest Dr Ste 205, N/A, Westlake Village, CA, 91362-3179, United States

Description

ActCel advanced bleeding control Topical Hemostatic Dressing 2in X 2in (5cm X 5cm) 4in X 4in Sterile Contents Soluble Regenerated Cellulose For Bleeding Control For external topical and temporary use only Sterility of contents guaranteed unless individual envelope is damaged or opened. Store at room temperature (41F-104F). Do not autoclave.

Reason

Coreva Health Science, LLC. is recalling ActCel Hemostatic Dressing due to customer literature and web sites promoting that it can help control bleeding from open wounds and in body cavities. ActCel is indicated as a prescription device for management of topical wounds and to temporarily control external surface bleeding.

Code Info

201303054, 201310418, 201406259, 201409367, 201502051, 201307297, 201310460, 201401023, 201406260, 201409368, 201303054, 201305137, 201401022, 201403096, 201404143

Distribution

U.S. distribution to the following; TX, NY, FL, VA, WA, and AZ. No foreign distribution. NOTE: The distribution list the firm provided does not include all consignees that purchased the product; rather target the consignees (distributors) who were observed to be using an unapproved marketing use.

Quantity

180,900